DE60311888T2 - Verwendung von hydroxamsäurederivaten zur herstellung von antitumorarzneimitteln - Google Patents

Verwendung von hydroxamsäurederivaten zur herstellung von antitumorarzneimitteln Download PDF

Info

Publication number
DE60311888T2
DE60311888T2 DE60311888T DE60311888T DE60311888T2 DE 60311888 T2 DE60311888 T2 DE 60311888T2 DE 60311888 T DE60311888 T DE 60311888T DE 60311888 T DE60311888 T DE 60311888T DE 60311888 T2 DE60311888 T2 DE 60311888T2
Authority
DE
Germany
Prior art keywords
manufacture
tumor
cells
antitumumorine
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60311888T
Other languages
German (de)
English (en)
Other versions
DE60311888D1 (de
Inventor
Flavio Leoni
Paolo Mascagni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Publication of DE60311888D1 publication Critical patent/DE60311888D1/de
Application granted granted Critical
Publication of DE60311888T2 publication Critical patent/DE60311888T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60311888T 2003-01-17 2003-12-10 Verwendung von hydroxamsäurederivaten zur herstellung von antitumorarzneimitteln Expired - Lifetime DE60311888T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000064A ITMI20030064A1 (it) 2003-01-17 2003-01-17 Uso dei derivati dell'acido idrossamico per la preparazione
ITMI20030064 2003-01-17
PCT/EP2003/014171 WO2004064824A1 (en) 2003-01-17 2003-12-10 Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments

Publications (2)

Publication Number Publication Date
DE60311888D1 DE60311888D1 (de) 2007-03-29
DE60311888T2 true DE60311888T2 (de) 2007-12-06

Family

ID=32750476

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60311888T Expired - Lifetime DE60311888T2 (de) 2003-01-17 2003-12-10 Verwendung von hydroxamsäurederivaten zur herstellung von antitumorarzneimitteln

Country Status (8)

Country Link
US (1) US8227515B2 (https=)
EP (1) EP1583523B1 (https=)
JP (1) JP4495599B2 (https=)
AU (1) AU2003290034A1 (https=)
DE (1) DE60311888T2 (https=)
ES (1) ES2282705T3 (https=)
IT (1) ITMI20030064A1 (https=)
WO (1) WO2004064824A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1392908B1 (it) * 2008-09-29 2012-04-02 Italfarmaco Spa Uso degli inibitori delle istone-deacetilasi per la cura di sindromi mieloproliferative philadelphia-negative

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283637B1 (it) * 1996-05-14 1998-04-23 Italfarmaco Spa Composti ad attivita' antinfiammatoria ed immunosoppressiva
KR20020070285A (ko) * 1999-11-23 2002-09-05 메틸진, 인크. 히스톤 디아세틸라제의 억제제
JPWO2002074298A1 (ja) * 2001-03-21 2004-07-08 小野薬品工業株式会社 Ｉｌ−６産生阻害剤
SE0101257D0 (sv) * 2001-04-06 2001-04-06 A & Science Invest Ab Treatment of whiplash associated disorder
ITMI20011733A1 (it) 2001-08-07 2003-02-07 Italfarmaco Spa Derivati dell'acido idrossamico inibitori degli enzimi istone deacetilasi, quali nuovi farmaci antiinfiammatori inibenti la sintesi di citoc
JPWO2003070691A1 (ja) * 2002-02-21 2005-06-09 財団法人大阪産業振興機構 Ｎ−ヒドロキシカルボキサミド誘導体

Also Published As

Publication number Publication date
DE60311888D1 (de) 2007-03-29
EP1583523B1 (en) 2007-02-14
EP1583523A1 (en) 2005-10-12
AU2003290034A1 (en) 2004-08-13
US20060063800A1 (en) 2006-03-23
JP2006514659A (ja) 2006-05-11
WO2004064824A1 (en) 2004-08-05
JP4495599B2 (ja) 2010-07-07
ES2282705T3 (es) 2007-10-16
US8227515B2 (en) 2012-07-24
ITMI20030064A1 (it) 2004-07-18

Similar Documents

Publication Publication Date Title
DE1792711C3 (de) Verwendung von Alkanolaminderivaten
DE3611194A1 (de) Cancerostatisches mittel
DE69415507T2 (de) Analoge von acylfulven als antitumormittel
DE69427591T2 (de) 7-(2-imidazolinylamino)quinolin-verbindungen als alpha-2 adrenorezeptor-agonisten
EP0193056A1 (de) Kombination von Flupirtin und anticholinergisch wirkenden Spasmolytika
DE2160946A1 (de) Aminosäureamide disubstituierter Phenathylamine
DE3877386T2 (de) Antikrebsverbindungen.
EP2987784A1 (de) Verbesserung der bioverfügbarkeit von wirkstoffen mit amidinfunktion in arzneimitteln
DE60225943T2 (de) Topoisomerase-giftmittel
DE60311888T2 (de) Verwendung von hydroxamsäurederivaten zur herstellung von antitumorarzneimitteln
DE69121551T2 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
DE69220050T2 (de) Verfahren zur inhibierung der fibrose
DE69318046T2 (de) Antikrebsbenzaldehydverbindungen
EP0338308A2 (de) Substituierte N-Glycosylamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
AT344151B (de) Verfahren zur herstellung von neuen naphthalinderivaten
DE69212267T2 (de) Echinocandin-B-Derivat
DE69113893T2 (de) 6,7-Disubstituierte 2-Aminotetraline als Immunomodulatoren und pharmazeutische Zusammensetzungen davon.
DE3134709A1 (de) Antineoplastisch wirkende titanverbindung und diese enthaltende arzneimittel
AT391699B (de) Verfahren zur herstellung neuer 4-chloro substituierter furo-(3,4-c)-pyridinderivate
DE3686688T2 (de) Verwendung von sulfanilamido quinoxalinen zur behandlung von neoplastischen krankheiten.
DE69007439T2 (de) Mittel gegen Tumore.
CH516593A (de) Verfahren zur Herstellung von neuen Estern von a-Aminobenzyl-penicillin
DE69119199T2 (de) Methode zur Hemmung von Tumorwachstum unter Verwendung von Xanthocillin-X-dimethylether
DE68904050T2 (de) Methode zur kontrolle von pneumocystis carinii.
DE3883696T2 (de) Anti-Krebs-Mittel und Reagenz zur Gewinnung von Revertanten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition